Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for constructing in-vitro recombinant epidermal model of analogous atopic dermatitis (AD) phenotype

A technology of atopic dermatitis and its construction method, which is applied in the field of in vitro recombinant epidermal model construction, which can solve the problems of insufficient accuracy and lack of atopic dermatitis-like phenotypes in animal AD models, shorten the modeling time, and avoid the genus differences, the effect of reducing individual differences

Inactive Publication Date: 2020-01-14
GUANGDONG BOXI BIO TECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] In order to solve the problem of the lack of a skin model of atopic dermatitis-like phenotype in the prior art and the lack of accuracy of pharmacological experiments using animal AD models, the present invention provides the construction of an in vitro recombinant epidermal model of atopic dermatitis-like phenotype method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for constructing in-vitro recombinant epidermal model of analogous atopic dermatitis (AD) phenotype
  • Method for constructing in-vitro recombinant epidermal model of analogous atopic dermatitis (AD) phenotype
  • Method for constructing in-vitro recombinant epidermal model of analogous atopic dermatitis (AD) phenotype

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Example 1: Construction of an in vitro recombinant epidermal model of atopic dermatitis-like phenotype.

[0033] Step (1): Preparation of Epidermal Cells

[0034] Take the primary keratinocytes, after recovery and expansion, use the P7 generation cells, digest with 2.5% trypsin digestion solution (100 mL PBS, 2.5 g trypsin), and make a single cell suspension with MCDB153 medium , according to 2.5×10 5 cells / mL, inoculated in culture flasks, placed at 37°C, 5% CO 2 cultivated under conditions;

[0035] Step (2): Submerged culture of epidermal cells

[0036] Preparation of cell culture medium I: Cell culture medium I was based on MCDB153, supplemented with insulin 2.5 μg / mL, isoproterenol 0.5 μM, hydrocortisone 0.1 μg / mL, epidermal growth factor 5 ng / mL, glandular Purine 30 μg / mL, transferrin 8 μg / mL, L-carnitine 0.05 mM and calcium chloride 0.2 mM.

[0037] Epidermal cells in the logarithmic growth phase were taken, and the cell density was 1.25×10 with cell culture...

Embodiment 2

[0042] Example 2: Construction of an in vitro recombinant epidermal model of atopic dermatitis-like phenotype

[0043] Step (1): Preparation of Epidermal Cells

[0044] Take the primary keratinocytes, after recovery and expansion, use the P3 generation cells, digest with trypsin digestion solution with a mass concentration of 2.5%, and make a single-cell suspension with MCDB153 medium, according to 1.0×10 5 cells / mL, inoculated in culture flasks, placed at 37°C, 5% CO 2 cultivated under conditions;

[0045] Step (2): Submerged culture of epidermal cells

[0046] Preparation of cell culture medium I: Cell culture medium I was based on MCDB153, supplemented with insulin 0.5 μg / mL, isoproterenol 0.1 μM, hydrocortisone 0.02 μg / mL, epidermal growth factor 1 ng / mL, glandular Purine 10 μg / mL, transferrin 5 μg / mL, L-carnitine 0.001 mM and calcium chloride 0.03 mM.

[0047] Epidermal cells in the logarithmic growth phase were taken, and the cell density was 1.25×10 with cell cultur...

Embodiment 3

[0052] Example 3: Construction of an in vitro recombinant epidermal model of atopic dermatitis-like phenotype

[0053] Step (1): Preparation of Epidermal Cells

[0054] Take the primary keratinocytes, after recovery and expansion, use the P7 generation cells, digest with trypsin digestion solution with a mass concentration of 2.5%, and make a single cell suspension with MCDB153 medium, according to 5×10 5 cells / mL, inoculated in culture flasks, placed at 37°C, 5% CO 2 cultivated under conditions;

[0055] Step (2): Submerged culture of epidermal cells

[0056] Preparation of cell culture medium I: Cell culture medium I was based on MCDB153, supplemented with insulin 5 μg / mL, isoproterenol 1 μM, hydrocortisone 0.2 μg / mL, epidermal growth factor 10 ng / mL, glandular Purine 50 μg / mL, transferrin 12 μg / mL, L-carnitine 0.1 mM and calcium chloride 0.2 mM.

[0057] Take the epidermal cells in the logarithmic growth phase, and make the cell density of 2.5×10 6 cells / mL of epiderma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention particularly relates to a method for constructing an in-vitro recombinant epidermal model of an analogous atopic dermatitis (AD) phenotype. The method is characterized by comprising thefollowing steps that (1) epidermal cells are prepared; (2) epidermal cells are subjected to undersurface culture; and (3) the in-vitro recombinant epidermal model is constructed. By adding specific substances in cell culture fluids at all stages, proliferation and differentiation of keratinocyte are regulated and controlled. The in-vitro recombinant epidermal model, constructed by adopting the method, of the analogous AD phenotype has a tissue slice structure and biochemical index change similar to the human skin under the AD pathological state, the constructed in-vitro recombinant epidermal model can actually simulate the pathological state of human AD skin, species difference and individual difference are reduced, and true effectiveness of the model is greatly improved.

Description

technical field [0001] The invention belongs to the technical field of tissue engineering, and in particular relates to a method for constructing an in vitro recombined epidermal model of atopic dermatitis-like phenotype. Background technique [0002] Atopic dermatitis (Atopic Dermatitis, AD) is a chronic, relapsing, inflammatory skin disease that occurs frequently in infants and children, but can also occur in adults. In the past 30 years, the incidence rate has gradually increased in all countries, affecting 15-30% of children and 2%-10% of adults. The main manifestations of the disease are intense itching, marked eczematous changes, and dry skin. Skin lesions are prone to occur on the face, flexion or extension sides of limbs, armpits, cubital fossa and other positions. [0003] The etiology of AD involves both environmental factors and intrinsic factors, and its pathogenesis mainly involves genetic factors (such as FLG, SPINK5, IL-4 / IL-4R, Gene Z, etc.), Th1 / Th2 immune...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/071
CPCC12N5/0625C12N2500/14C12N2500/25C12N2500/30C12N2500/32C12N2500/36C12N2500/40C12N2501/11C12N2501/17C12N2501/22C12N2501/2304C12N2501/2313C12N2501/25C12N2501/39C12N2501/81
Inventor 吴迪卢永波邓志宏刘文佳金岩
Owner GUANGDONG BOXI BIO TECH CO LTD